Biblio Discovery — Demo Discovery Service

29 hasil untuk "Pitcher, Toni"

Menampilkan 1–20 · 2,92 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Variations in the patterns of prevalence and therapy in Australasian Parkinson’s disease patients of different ethnicities

    Alamri, Yassar; Pitcher, Toni; Anderson, Tim J

    BMJ Neurol Open · 2020 · Inggris · PubMed Central

    Parkinson’s disease (PD) is the second most common neurodegenerative disease in the elderly after Alzheimer’s disease. It is expected that PD cumulative incidence will increase in the future, as there are far more people surviving into late age than there ever used to be. While most commonly…

  2. Artikel Jurnal Teks lengkap

    Changes of plasma cGP/IGF‐1 molar ratio with age is associated with cognitive status of Parkinson disease

    Fan, Dawei; Pitcher, Toni; Dalrymple‐Alford, John dkk.

    Alzheimers Dement (Amst) · 2020 · Inggris · PubMed Central

    OBJECTIVE: Cognitive impairment is a common feature of Parkinson disease (PD), for which age is a major contributing factor. Insulin‐like growth factor‐1 (IGF‐1) declines with age and contributes to age‐related cognitive impairment in PD. Cyclic glycine‐proline (cGP) is a metabolite of IGF‐1 and…

  3. Artikel Jurnal Teks lengkap

    Clinical features and mortality outcomes of people transferred from prison to forensic mental health units: a nationwide 14-year retrospective cohort study

    Foulds, James A.; Cunningham, Ruth; Pitcher, Toni L. dkk.

    Soc Psychiatry Psychiatr Epidemiol · 2025 · Inggris · PubMed Central

    PURPOSE: To describe a cohort of people transferred from prison to psychiatric hospital care and their mortality outcomes. METHODS: Retrospective nationwide cohort of people (n = 1320) transferred from prison to a psychiatric hospital in New Zealand from 2009 to 2022. Follow up commenced at the…

  4. Artikel Jurnal Teks lengkap

    A Multi‐Step Model of Parkinson's Disease Pathogenesis

    Le Heron, Campbell; MacAskill, Michael; Mason, Deborah dkk.

    Mov Disord · 2021 · Inggris · PubMed Central

    BACKGROUND: Parkinson's disease (PD) may result from the combined effect of multiple etiological factors. The relationship between disease incidence and age, as demonstrated in the cancer literature, can be used to model a multistep pathogenic process, potentially affording unique insights into…

  5. Artikel Jurnal Teks lengkap

    Enhanced high-frequency membrane potential fluctuations control spike output in striatal fast-spiking interneurones in vivo

    Schulz, Jan M; Pitcher, Toni L; Savanthrapadian, Shakuntala dkk.

    J Physiol · 2011 · Inggris · PubMed Central

    ABSTRACT: Fast-spiking interneurones (FSIs) constitute a prominent part of the inhibitory microcircuitry of the striatum; however, little is known about their recruitment by synaptic inputs in vivo. Here, we report that, in contrast to cholinergic interneurones (CINs), FSIs (n = 9) recorded in…

  6. Artikel Jurnal Teks lengkap

    Cyclic Glycine-Proline (cGP) Normalises Insulin-Like Growth Factor-1 (IGF-1) Function: Clinical Significance in the Ageing Brain and in Age-Related Neurological Conditions

    Guan, Jian; Li, Fengxia; Kang, Dali dkk.

    Molecules · 2023 · Inggris · PubMed Central

    Insulin-like growth factor-1 (IGF-1) function declines with age and is associated with brain ageing and the progression of age-related neurological conditions. The reversible binding of IGF-1 to IGF binding protein (IGFBP)-3 regulates the amount of bioavailable, functional IGF-1 in circulation…

  7. Artikel Jurnal Teks lengkap

    Positive Association of Ascorbate and Inverse Association of Urate with Cognitive Function in People with Parkinson’s Disease

    Spencer, Emma S.; Pitcher, Toni; Veron, Gabriel dkk.

    Antioxidants (Basel) · 2020 · Inggris · PubMed Central

    Oxidative stress is thought to contribute to the aetiology of neurological disorders such as Parkinson’s disease. Ascorbate (vitamin C) is a potent antioxidant and is associated with neurological and cognitive function. In this study we assessed the ascorbate status of a cohort of people with…

  8. Artikel Jurnal Teks lengkap

    Reduced striatal volumes in Parkinson’s disease: a magnetic resonance imaging study

    Pitcher, Toni L; Melzer, Tracy R; MacAskill, Michael R dkk.

    Transl Neurodegener · 2012 · Inggris · PubMed Central

    BACKGROUND: The presence and extent of structural changes in the brain as a consequence of Parkinson’s disease (PD) is still poorly understood. METHODS: High-resolution 3-tesla T1-weighted structural magnetic resonance images in sixty-five PD and 27 age-matched healthy control participants were…

    Juga tersedia di: DOAJ

  9. Artikel Jurnal Teks lengkap

    Caregiver burden is increased in Parkinson’s disease with mild cognitive impairment (PD-MCI)

    Jones, Ann J.; Kuijer, Roeline G.; Livingston, Leslie dkk.

    Transl Neurodegener · 2017 · Inggris · PubMed Central

    BACKGROUND: There is limited evidence on caregiver outcomes associated with mild cognitive impairment in patients with Parkinson’s disease (PD-MCI) and the coping strategies used by these caregivers. METHODS: To investigate this relationship, we examined levels of burden, depression, anxiety…

  10. Artikel Jurnal Teks lengkap

    Tracking Parkinson’s Disease over One Year with Multimodal Magnetic Resonance Imaging in a Group of Older Patients with Moderate Disease

    Melzer, Tracy R.; Myall, Daniel J.; MacAskill, Michael R. dkk.

    PLoS One · 2015 · Inggris · PubMed Central

    BACKGROUND & OBJECTIVES: Cross-sectional magnetic resonance imaging (MRI) suggests that Parkinson’s disease (PD) is associated with changes in cerebral tissue volume, diffusion tensor imaging metrics, and perfusion values. Here, we performed a longitudinal multimodal MRI study—including structural…

  11. Artikel Jurnal Teks lengkap

    Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study

    Wood, Kyla-Louise; Myall, Daniel J; Livingston, Leslie dkk.

    NPJ Parkinsons Dis · 2016 · Inggris · PubMed Central

    The Movement Disorder Society Task Force (MDS-TF) has proposed diagnostic criteria for mild cognitive impairment in Parkinson’s disease (PD-MCI). We hypothesized that the risk of dementia (PDD) varies across the different cutoff schemes allowed. A longitudinal study followed 121 non-demented PD…

  12. Artikel Jurnal Teks lengkap

    Extracellular vesicle biomarkers for cognitive impairment in Parkinson’s disease

    Blommer, Joseph; Pitcher, Toni; Mustapic, Maja dkk.

    Brain · 2022 · Inggris · PubMed Central

    Besides motor symptoms, many individuals with Parkinson’s disease develop cognitive impairment perhaps due to coexisting α-synuclein and Alzheimer’s disease pathologies and impaired brain insulin signalling. Discovering biomarkers for cognitive impairment in Parkinson’s disease could help clarify…

  13. Artikel Jurnal Teks lengkap

    Early phase Amyloid‐PET reproduces metabolic signatures of cognitive decline in Parkinson's disease

    Heron, Campbell Le; Aye, William; Stark, Megan dkk.

    Alzheimers Dement · 2025 · Inggris · PubMed Central

    BACKGROUND: Establishing practical and effective diagnostic pathways for people with cognitive impairment is a crucial international research priority. Traditional (late‐phase) analysis of an amyloid‐beta (Aβ) PET scan (∼90 minutes after radiotracer injection) provides important information about…

  14. Artikel Jurnal Teks lengkap

    Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease Onset

    Schierding, William; Farrow, Sophie; Fadason, Tayaza dkk.

    Mov Disord · 2020 · Inggris · PubMed Central

    BACKGROUND: GBA mutations are numerically the most significant genetic risk factor for Parkinson's disease (PD), yet these mutations have low penetrance, suggesting additional mechanisms. OBJECTIVES: The objective of this study was to determine if the penetrance of GBA in PD can be explained by…

  15. Artikel Jurnal Teks lengkap

    Neuropsychiatric Symptoms Are Associated with Dementia in Parkinson's Disease but Not Predictive of it

    Horne, Kyla‐Louise; MacAskill, Michael R.; Myall, Daniel J. dkk.

    Mov Disord Clin Pract · 2021 · Inggris · PubMed Central

    BACKGROUND: Neuropsychiatric symptoms in Parkinson's disease (PD) may increase dementia (PDD) risk. The predictive value of these symptoms, however, has not been compared to clinical and demographic predictors of future PDD. OBJECTIVES: Determine if neuropsychiatric symptoms are useful markers of…

  16. Artikel Jurnal Teks lengkap

    Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson’s disease

    Melzer, Tracy R.; Watts, Richard; MacAskill, Michael R. dkk.

    Brain · 2011 · Inggris · PubMed Central

    There is a need for objective imaging markers of Parkinson’s disease status and progression. Positron emission tomography and single photon emission computed tomography studies have suggested patterns of abnormal cerebral perfusion in Parkinson’s disease as potential functional biomarkers. This…

  17. Artikel Jurnal Teks lengkap

    Early‐phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's disease

    Aye, William W. T.; Stark, Megan R.; Horne, Kyla‐Louise dkk.

    Alzheimers Dement (Amst) · 2024 · Inggris · PubMed Central

    INTRODUCTION: Recent work suggests that amyloid beta (Aβ) positron emission tomography (PET) tracer uptake shortly after injection (“early phase”) reflects brain metabolism and perfusion. We assessed this modality in a predominantly amyloid‐negative neurodegenerative condition, Parkinson's disease…

  18. Artikel Jurnal Teks lengkap

    Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease

    Melzer, Tracy R.; Stark, Megan R.; Keenan, Ross J. dkk.

    Front Neurol · 2019 · Inggris · PubMed Central

    The extent to which Alzheimer neuropathology, particularly the accumulation of misfolded beta-amyloid, contributes to cognitive decline and dementia in Parkinson's disease (PD) is unresolved. Here, we used Florbetaben PET imaging to test for any association between cerebral amyloid deposition and…

  19. Artikel Jurnal Teks lengkap

    The New Zealand Parkinson’s progression programme

    MacAskill, Michael R.; Pitcher, Toni L.; Melzer, Tracy R. dkk.

    J R Soc N Z · 2022 · Inggris · PubMed Central

    We describe the New Zealand Parkinson’s Progression Programme (NZP3), its goals, findings, and future plans. To date, 354 people with Parkinson’s disease and 89 healthy older controls have participated over a 14-year period. A major focus of the programme has been the characterisation of current…